Skip to main content
Log in

Effects of nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester on duodenal alkaline secretory and ulcerogenic responses induced by mepirizole in rats

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The inhibition of nitric oxide (NO) production by NO synthase inhibitors stimulates HCO 3 secretion in the rat duodenal mucosa. Therefore, we examined the effects of NG-nitro-l-arginine methyl ester (l-NAME, the NO synthase inhibitor) and nitroprusside (the exogenous NO donor) on the duodenal HCO 3 and ulcerogenic responses in anesthetized rats. Animals were administered mepirizole (200 mg/kg, subcutaneously) for induction of duodenal ulcers, and gastric acid and duodenal HCO 3 secretions were measured with or without pretreatment withl-NAME (5 mg/kg, intravenously) or nitroprusside (4 mg/kg, intravenously). Mepirizole increased acid secretion, decreased the acid-induced duodenal HCO 3 secretion, and induced hemorrhagic lesions in the proximal duodenum. The inhibition of NO production byl-NAME potentiated the acid secretory response, increased the duodenal HCO 3 secretion, and prevented the duodenal lesions, and these changes were all antagonized by simultaneous administration ofl-arginine (200 mg/kg, intravenously) but notd-arginine. On the other hand, nitroprusside slightly reduced the acid response but further decreased the HCO 3 output, resulting in aggravation of duodenal lesions induced by mepirizole. These data suggest that the inhibition of endogenous NO production by the NO synthase inhibitorl-NAME increases duodenal HCO 3 secretion and protects the duodenal mucosa against acid injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MacNaughton K, Cirino G, Wallace JE: Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 45:1869–1876, 1989

    PubMed  Google Scholar 

  2. Whittle BJR, Lopes-Bermonte J, Moncada S: Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 99:607–611, 1990

    PubMed  Google Scholar 

  3. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142, 1991

    PubMed  Google Scholar 

  4. Pique JM, Whittle BJR, Esplugues JV: The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 174:293–296, 1989

    PubMed  Google Scholar 

  5. Martinez-Cuesta MA, Barrachina MD, Pique JM, Whittle BJR, Esplugues JV: The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion. Eur J Pharmacol 218:351–354, 1992

    PubMed  Google Scholar 

  6. Takeuchi K, Ohuchi T, Okabe S: Endogenous nitric oxide in gastric alkaline response in the rat stomach after damage. Gastroenterology 106:367–374, 1994

    PubMed  Google Scholar 

  7. Brown JF, Hanson PJ, Whittle BJR: Nitric oxide donors increase mucus gel thickness in rat stomach. Eur J Pharmacol 223:103–104, 1992

    PubMed  Google Scholar 

  8. Takeuchi K, Ohuchi T, Miyake H, Okabe S: Stimulation by nitric oxide synthase inhibitors of gastric and duodenal HCO 3 secretion in rats. J Pharmacol Exp Ther 266:1512–1519, 1993

    PubMed  Google Scholar 

  9. Selye H, Szabo S: Experimental model for production of perforating duodenal ulcers by cysteamine in the rat. Nature 244:458–459, 1973

    PubMed  Google Scholar 

  10. Okabe S, Ishihara Y, Inoo H, Tanaka H: Mepirizole-induced duodenal ulcers in rats and their pathogenesis. Dig Dis Sci 27:242–249, 1982

    PubMed  Google Scholar 

  11. Tanaka H, Ueki S, Ohno T, Takeuchi K, Okabe S: Pathogenic mechanisms involved in mepirizole-induced duodenal damage in the rat. Jpn J Pharmacol 42:383–396, 1986

    PubMed  Google Scholar 

  12. Takeuchi K, Furukawa O, Tanaka H, Okabe S: A new model of duodenal ulcers induced in rats by indomethacin plus histamine. Gastroenterology 90:636–645, 1986

    PubMed  Google Scholar 

  13. Niida H, Takeuchi K, Okabe S: Role of thyrotropin-releasing hormone in acid secretory response induced by lowering of body temperature in the rat. Eur J Pharmacol 198:137–142, 1991

    PubMed  Google Scholar 

  14. Ueshima K, Takeuchi K, Ohuchi T, Okabe S: Acid secretory and duodenal ulcerogenic responses induced by mepirizole in anesthetized rats: Relation to body temperature. Dig Dis Sci 39:1625–1632, 1994

    PubMed  Google Scholar 

  15. Dunnett CW: A multiple comparison procedure for comparing several treatments with a control. Am J Stat Assoc 50:1096–1121, 1955

    Google Scholar 

  16. Lippe T, Holzer P: Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperemia due to acid back-diffusion. Br J Pharmacol 105:708–714, 1992

    PubMed  Google Scholar 

  17. Szabo S, Reynolds ES, Lichtenberger LM, Haith LR, Dzau VJ: Pathogenesis of duodenal ulcer. Gastric acidity caused by propionitrile and cysteamine in rats. Res Commun Chem Pathol Pharmacol 16:311–323, 1977

    PubMed  Google Scholar 

  18. Briden A, Flemstrom G, Kivilaakso E: Cysteamine and propionitrile inhibit the rise of duodenal mucosal alkaline secretion in response to luminal acid in rats. Gastroenterology 88:295–302, 1985

    PubMed  Google Scholar 

  19. Isenberg JI, Selling JA, Hogan DL, Koss MA: Impaired proximal duodenal mucosal bicarbonate secretion in duodenal ulcer patients. N Engl J Med 316:374–379, 1987

    PubMed  Google Scholar 

  20. Tabata K, Jacobson ED, Chen MH, Murphy RF, Joffe SN: Decrease in alkaline secretion during duodenal ulceration induced by mepirizole in rats. Gastroenterology 87:396–401, 1984

    PubMed  Google Scholar 

  21. Kurebayashi Y, Asano M, Hashizume T, Akashi A: Gastric hyperacidity and duodenal ulcer formation induced by dulcerozine in rats. Jpn J Pharmacol 36:121–123, 1984

    PubMed  Google Scholar 

  22. Lefebvre RA: Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus. Arch Int Pharmacodyn 280(suppl):110–136, 1986

    PubMed  Google Scholar 

  23. Lefebvre J, Hasrat J, Gobert A: Influence of NG-nitro-l-arginine methyl ester on yagally induced gastric relaxation in the anesthetized rat. Br J Pharmacol 105:315–320, 1992

    PubMed  Google Scholar 

  24. Takeuchi K, Ohuchi T, Tachibana M, Okabe S: The mechanism underlying stimulation of gastric HCO 3 secretion by the nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester in rats. J Gastroenterol Hepatol 1994 9:S50-S54, 1994

    PubMed  Google Scholar 

  25. Takeuchi K, Takehara K, Okabe S: Effects of endogenous and exogenous nitric oxide on gastric alkaline secretion in anesthetized rats. Asia Pac J Pharmacol 1995 (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takeuchi, K., Ohuchi, T. & Okabe, S. Effects of nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester on duodenal alkaline secretory and ulcerogenic responses induced by mepirizole in rats. Digest Dis Sci 40, 670–677 (1995). https://doi.org/10.1007/BF02064389

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02064389

Key Words

Navigation